Screener
Phathom Pharmaceuticals, Inc. PHAT Enterprise value
Enterprise value at other companies
Other financials
Where this comes from
Calculated from Phathom Pharmaceuticals, Inc.’s reported figures.
The source filing: Phathom Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:05 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324867
FAQ
- What is Phathom Pharmaceuticals, Inc.'s enterprise value?
- Phathom Pharmaceuticals, Inc. (PHAT) reported enterprise value of $849.99M in Q2 2026.
- How has Phathom Pharmaceuticals, Inc.'s enterprise value changed year-over-year?
- Phathom Pharmaceuticals, Inc.'s enterprise value increased by 15.2% year-over-year, from $737.78M to $849.99M.
- What is the long-term trend for Phathom Pharmaceuticals, Inc.'s enterprise value?
- Over 5 years (2020 to 2025), Phathom Pharmaceuticals, Inc.'s enterprise value has grown at a 9.2% compound annual growth rate (CAGR), from $812.72M to $1.26B.
- What does enterprise value mean?
- Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.
Ask your AI about Phathom Pharmaceuticals, Inc.'s enterprise value.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude